Literature DB >> 3316712

An overview of intravesical therapy for superficial bladder tumors.

H W Herr1, V P Laudone, W F Whitmore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3316712     DOI： 10.1016/s0022-5347(17)43644-5

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  27 in total

1.  Long-term BCG immune therapy of superficial bladder tumours.

Authors:  L Somogyi; A Szántó; L Polyák; F Baranyay; M Drinóczy
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

Review 2.  Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Authors:  M S Highley; A T van Oosterom; R A Maes; E A De Bruijn
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 3.  Tumors of the kidney, ureter, and bladder.

Authors:  W A See; R D Williams
Journal:  West J Med       Date:  1992-05

Review 4.  Bladder cancer.

Authors:  A P van der Meijden
Journal:  BMJ       Date:  1998-11-14

5.  Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer.

Authors:  F Yalçinkaya; L Kamiş; O Ozteke; B Günlüsoy; O Yigitbaşi; S Unal
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 6.  Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients.

Authors:  H W Herr
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

7.  Biopsies of the normal-appearing urothelium in primary bladder cancer.

Authors:  Davor Librenjak; Zana Saratlija Novakovic; Marijan Situm; Kazimir Milostic; Mario Duvnjak
Journal:  Urol Ann       Date:  2010-05

8.  A randomized trial of early intravesical instillation of epirubicin in superficial bladder cancer. The Nagoya University Urological Oncology Group.

Authors:  K Okamura; T Murase; K Obata; S Ohshima; Y Ono; T Sakata; Y Hasegawa; T Shimoji; K Miyake
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 9.  Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.

Authors:  J P Crew; T S O'Brien; A L Harris
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

10.  Intravesical epirubicin in the prophylaxis of superficial bladder cancer.

Authors:  F Sengör; M Beysel; K Erdoğan; A Erol; D Tuzluoğlu
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.